These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27196002)

  • 61. Milk-derived Extracellular Vesicles for Therapeutic Delivery of Small Interfering RNAs.
    Matsuda A; Patel T
    Methods Mol Biol; 2018; 1740():187-197. PubMed ID: 29388145
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus.
    Ortega A; Martinez-Arroyo O; Forner MJ; Cortes R
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374908
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exosomes for drug delivery - a novel application for the mesenchymal stem cell.
    Lai RC; Yeo RW; Tan KH; Lim SK
    Biotechnol Adv; 2013; 31(5):543-51. PubMed ID: 22959595
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In situ single step detection of exosome microRNA using molecular beacon.
    Lee JH; Kim JA; Kwon MH; Kang JY; Rhee WJ
    Biomaterials; 2015 Jun; 54():116-25. PubMed ID: 25907045
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Emerging RNA-based drugs: siRNAs, microRNAs and derivates.
    Pereira TC; Lopes-Cendes I
    Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):217-32. PubMed ID: 22697266
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges.
    Ubanako P; Mirza S; Ruff P; Penny C
    Front Mol Biosci; 2024; 11():1447953. PubMed ID: 39355533
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA.
    de Martimprey H; Vauthier C; Malvy C; Couvreur P
    Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exosomes as novel bio-carriers for gene and drug delivery.
    Jiang XC; Gao JQ
    Int J Pharm; 2017 Apr; 521(1-2):167-175. PubMed ID: 28216464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes.
    Kim H; Yun N; Mun D; Kang JY; Lee SH; Park H; Park H; Joung B
    Biochem Biophys Res Commun; 2018 May; 499(4):803-808. PubMed ID: 29621543
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delivery vehicles for small interfering RNA in vivo.
    de Fougerolles AR
    Hum Gene Ther; 2008 Feb; 19(2):125-32. PubMed ID: 18257677
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vivo imaging of the systemic delivery of small interfering RNA.
    Ifediba MA; Moore A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):428-37. PubMed ID: 22228711
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Natural Carriers for siRNA Delivery.
    Karunaratne DN; Jafari M; Ranatunga RJ; Siriwardhana A
    Curr Pharm Des; 2015; 21(31):4529-40. PubMed ID: 26486140
    [TBL] [Abstract][Full Text] [Related]  

  • 74. On the delivery of small interfering RNAs into mammalian cells.
    Sioud M
    Expert Opin Drug Deliv; 2005 Jul; 2(4):639-51. PubMed ID: 16296791
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications.
    Amiri A; Bagherifar R; Ansari Dezfouli E; Kiaie SH; Jafari R; Ramezani R
    J Transl Med; 2022 Mar; 20(1):125. PubMed ID: 35287692
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Liposomes as siRNA delivery vectors.
    Bochicchio S; Dalmoro A; Barba AA; Grassi G; Lamberti G
    Curr Drug Metab; 2014; 15(9):882-92. PubMed ID: 25658127
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.
    Srinivas L; S D; Kgk D; Malla RR
    Crit Rev Oncog; 2019; 24(2):179-190. PubMed ID: 31679212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy.
    Zhang Y; Liu Q; Zhang X; Huang H; Tang S; Chai Y; Xu Z; Li M; Chen X; Liu J; Yang C
    J Nanobiotechnology; 2022 Jun; 20(1):279. PubMed ID: 35701788
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle.
    Lässer C
    Expert Opin Biol Ther; 2015 Jan; 15(1):103-17. PubMed ID: 25363342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.